Source:http://linkedlifedata.com/resource/pubmed/id/15514263
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2004-10-29
|
pubmed:abstractText |
Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) are important for homocysteine remethylation. This study was designed to determine the influence of genetic variants (MTHFR 677C-->T, MTHFR 1298A-->C, and MTRR 66A-->G), folate, and vitamin B-12 status on plasma homocysteine in women (20-30 y; n = 362). Plasma homocysteine was inversely (P < 0.0001) associated with serum folate and plasma vitamin B-12 regardless of genotype. Plasma homocysteine was higher (P < 0.05) for women with the MTHFR 677 TT/1298 AA genotype combination compared with the CC/AA, CC/AC, and CT/AA genotypes. Women with the MTHFR 677 TT/MTRR 66 AG genotype had higher (P < 0.05) plasma homocysteine than all other genotype combinations except the TT/AA and TT/GG genotypes. There were 5.4-, 4.3-, and 3.8-fold increases (P < 0.001) in risk for plasma homocysteine in the top 5, 10, and 20%, respectively, of the homocysteine distribution for subjects with the MTHFR 677 TT compared with the CC and CT genotypes. Predicted plasma homocysteine was inversely associated with serum folate (P = 0.003) and plasma vitamin B-12 (P = 0.002), with the degree of correlation dependent on MTHFR 677C-->T genotype. These data suggest that coexistence of the MTHFR 677 TT genotype with the MTRR 66A-->G polymorphism may exacerbate the effect of the MTHFR variant alone. The potential negative effect of combined polymorphisms of the MTHFR and MTRR genes on plasma homocysteine in at-risk population groups with low folate and/or vitamin B-12 status, such as women of reproductive potential, deserves further investigation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ferredoxin-NADP Reductase,
http://linkedlifedata.com/resource/pubmed/chemical/Folic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Homocysteine,
http://linkedlifedata.com/resource/pubmed/chemical/Methylenetetrahydrofolate...,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin B 12,
http://linkedlifedata.com/resource/pubmed/chemical/methionine synthase reductase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-3166
|
pubmed:author |
pubmed-author:BaileyLynn BLB,
pubmed-author:DavisSteven RSR,
pubmed-author:DunwoodyKristina M von-CastelKM,
pubmed-author:GregoryJesse FJF3rd,
pubmed-author:KauwellGail P AGP,
pubmed-author:ManevalDavid RDR,
pubmed-author:QuinlivanEoin PEP,
pubmed-author:ShelnuttKarla PKP,
pubmed-author:TheriaqueDouglas WDW,
pubmed-author:VaughnJaimie DJD
|
pubmed:issnType |
Print
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2985-90
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15514263-Adult,
pubmed-meshheading:15514263-Dietary Supplements,
pubmed-meshheading:15514263-Female,
pubmed-meshheading:15514263-Ferredoxin-NADP Reductase,
pubmed-meshheading:15514263-Folic Acid,
pubmed-meshheading:15514263-Gene Frequency,
pubmed-meshheading:15514263-Genotype,
pubmed-meshheading:15514263-Homocysteine,
pubmed-meshheading:15514263-Homozygote,
pubmed-meshheading:15514263-Humans,
pubmed-meshheading:15514263-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:15514263-Polymorphism, Genetic,
pubmed-meshheading:15514263-Vitamin B 12
|
pubmed:year |
2004
|
pubmed:articleTitle |
Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant.
|
pubmed:affiliation |
Food Science and Human Nutrition Department, University of Florida, Gainesville, FL 32611, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|